What is Rexon-Eye®?
Rexon-Eye® is a non-invasive medical device designed specifically for the treatment of dry eye disease. The technology delivers low-intensity Quantum Molecular Resonance (QMR) energy through specially designed eye masks while the patient relaxes comfortably during treatment.
QMR technology has been developed to stimulate cellular activity without generating significant heat or causing tissue damage. This eye treatment aims to improve the function of the structures involved in maintaining a healthy ocular surface, including the lacrimal functional unit responsible for tear production.
Unlike eye drops that provide temporary lubrication, Rexon-Eye seeks to support the body’s natural mechanisms involved in tear film maintenance and ocular surface health.
How Does Quantum Molecular Resonance (QMR) Work?
The ocular surface is a complex biological system consisting of the cornea, conjunctiva, eyelids, meibomian glands, nerves, and tear-producing structures. When these systems become dysfunctional, symptoms of dry eye can develop.
Quantum Molecular Resonance technology delivers specific low-frequency electrical fields that interact with tissues at a cellular level.
Research suggests that QMR may:
- Support cellular metabolism and activity
- Promote tissue repair mechanisms
- Improve communication between cells
- Enhance ocular surface health
- Support tear film stability
- Improve the function of structures involved in tear production
By addressing cellular dysfunction rather than simply replacing tears, Rexon-Eye offers a different treatment approach compared with traditional lubricating eye drops.
Who Can Benefit from Rexon-Eye Treatment?
Rexon-Eye may be suitable for patients with a range of dry eye conditions, particularly those who continue to experience symptoms despite conventional treatment.
Aqueous Deficient Dry Eye
Aqueous deficient dry eye occurs when the eyes do not produce enough tears. Patients often experience:
- Persistent dryness
- Burning sensations
- Light sensitivity
- Foreign body sensation
- Blurred vision
Rexon-Eye may help support the structures involved in tear production and is often considered for patients with moderate to severe aqueous deficiency.
Meibomian Gland Dysfunction (MGD)
Although treatments such as IPL and Low Level Light Therapy are often the primary treatments for MGD and inflammation, Rexon-Eye may be used as part of a comprehensive treatment strategy to improve overall ocular surface function.
Chronic Dry Eye Disease
Patients who have experienced symptoms for months or years and have not achieved adequate relief with lubricants alone may benefit from a more advanced treatment approach.
Post-Surgical Dry Eye
Some individuals develop dry eye symptoms following procedures such as LASIK, cataract surgery, or refractive lens exchange. Rexon-Eye may be considered where ocular surface dysfunction contributes to ongoing symptoms.
Autoimmune-Related Dry Eye
Patients with conditions such as Sjögren’s syndrome or other autoimmune disorders frequently experience significant ocular dryness. Rexon-Eye may form part of a multi-treatment management strategy alongside other dry eye therapies.
What Happens During a Rexon-Eye Treatment?
Rexon eye-treatment is a comfortable and straightforward treatment method that supports natural healing within the eye. Below is the general treatment process.
Before Treatment
You will undergo a comprehensive dry eye assessment which may include:
- Tear film analysis
- Meibography
- Lipid layer assessment
- Ocular surface staining
- Tear production testing
- Evaluation of inflammation and ocular surface health
During Rexon-Eye Treatment
Special treatment masks are placed over the closed eyelids.
Patients then relax comfortably while the device delivers QMR energy. The treatment is painless and most patients feel very little during the procedure.
Rexon-Eye Treatment Duration
Each session typically lasts around 20 minutes.
A treatment course generally consists of four sessions delivered over several weeks, although recommendations may vary depending on the severity and nature of your dry eye disease.
What Does Rexon-Eye Treatment Feel Like?
Most patients find Rexon-Eye extremely comfortable.
The treatment:
- Is non-invasive
- Does not require injections
- Does not involve surgery
- Produces no significant heat
- Requires no recovery time
Many patients use the treatment session as an opportunity to relax.
Following treatment, normal daily activities can usually be resumed immediately.
Clinical Evidence for Rexon-Eye
Emerging clinical studies have reported improvements in both symptoms and objective dry eye measurements following treatment with Quantum Molecular Resonance technology.
Published research has demonstrated improvements in:
- Dry eye symptom scores
- Tear film stability
- Ocular surface health
- Corneal staining
- Patient comfort
As with all dry eye treatments, results vary between individuals. The greatest improvements are often seen when treatment is integrated into a personalised management strategy based on detailed diagnostic findings.
Rexon-Eye® vs Other Dry Eye Treatments
Many patients benefit from combining multiple dry eye treatments rather than relying on a single form of eye therapy.
Artificial Tears
Offer temporary lubrication and dry eye symptom relief
Punctal Plugs to reduce tear drainage
Reduces tear drainage
IPL (OptiLight)Meibomian gland dysfunction and inflammation
A dry eye treatment that targets meibomian gland dysfunction and inflammation
Low Level Light Therapy (LLLT)
Supports meibomian gland function.
Rexon-Eye (QMR)
A treatment that targets cellular stimulation and ocular surface function.
Why Choose Dry Eye Centre for Rexon-Eye Treatment?
Dry Eye Centre is one of the UK’s leading dedicated dry eye clinics.
Our approach focuses on identifying the underlying causes of symptoms rather than simply recommending eye drops.
Patients benefit from:
Advanced Dry Eye Diagnostics
Personalised Treatment Plans
Low Level Light Therapy (LLLT)
Punctal Plugs and Lacrifill
IPL (OptiLight)
Specialist Clinicians With Extensive Dry Eye Expertise
Management Of Complex And Severe Dry Eye Disease
Frequently Asked Questions
Rexon-Eye is generally well tolerated and non-invasive. Your clinician will discuss any potential risks and suitability during your consultation.
Yes. Many patients benefit from combination therapy when multiple factors contribute to their dry eye disease.
Dry eye disease is typically a chronic condition. Rexon-Eye aims to improve ocular surface health and reduce symptoms, but ongoing management may still be required.
Most treatment protocols involve four sessions. Some patients may require additional treatment depending on the severity of their condition.
Some patients notice improvement within weeks of treatment, while others experience more gradual changes over several months.
No. Most patients find the treatment comfortable and relaxing.
Potentially. Following a comprehensive assessment, we can determine whether Rexon-Eye may be beneficial as part of a personalised treatment plan.
Rexon-Eye is generally well tolerated and non-invasive. Your clinician will discuss any potential risks and suitability during your consultation.
Yes. Many patients benefit from combination therapy when multiple factors contribute to their dry eye disease.
Dry eye disease is typically a chronic condition. Rexon-Eye aims to improve ocular surface health and reduce symptoms, but ongoing management may still be required.
Most treatment protocols involve four sessions. Some patients may require additional treatment depending on the severity of their condition.
Some patients notice improvement within weeks of treatment, while others experience more gradual changes over several months.
No. Most patients find the treatment comfortable and relaxing.
Potentially. Following a comprehensive assessment, we can determine whether Rexon-Eye may be beneficial as part of a personalised treatment plan.